These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6006957)

  • 21. [Antipressor and vasodilator substances of the kidney (review of foreign literature)].
    Markov KhM
    Urol Nefrol (Mosk); 1969; 34(4):61-5. PubMed ID: 4904821
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraglomerular hypertension: implications and drug treatment.
    Anderson S; Brenner BM
    Annu Rev Med; 1988; 39():243-53. PubMed ID: 3285775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of arterial hypertension in non-oliguric renal failure].
    Beretta-Piccoli C
    Schweiz Med Wochenschr; 1989 Jul; 119(29):1016-22. PubMed ID: 2678436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive agents in renal disease.
    White RP
    Am J Med; 1977 Apr; 62(4):539-41. PubMed ID: 851127
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of hypotensive therapy on kidney function in hypertensive states].
    Shershnev VG; Shcherban' NN; Gorodetskiĭ AL
    Ter Arkh; 1973 Oct; 45(10):85-8. PubMed ID: 4783250
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of antihypertensive therapy on the course of renal failure.
    Lederle RM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S69-72. PubMed ID: 1283193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA/saline hypertensive and renal hypertensive rats.
    Takeda K; Nakagawa Y; Chin WP; Imai S
    Jpn J Pharmacol; 1982 Apr; 32(2):283-9. PubMed ID: 7098145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha-methyldopa and renal function in arterial hypertension].
    Pessina AC; Hlede M; Pigato R; Palatini P; Dal Palù C
    Clin Ter; 1980 May; 93(3):287-94. PubMed ID: 7449342
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
    Kotzaurek R; Schmidt P; Widhalm F
    Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal denervation therapy for hypertension.
    Thukkani AK; Bhatt DL
    Circulation; 2013 Nov; 128(20):2251-4. PubMed ID: 24218440
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of antihypertensive agents on intrarenal hemodynamics].
    Guedon J
    Presse Med; 1988 Oct; 17(34):1729-31. PubMed ID: 2978304
    [No Abstract]   [Full Text] [Related]  

  • 32. [How I treat.... hypertension with non-diabetic renal insufficiency].
    Krzesinski JM
    Rev Med Liege; 1994 Jul; 49(7):373-4. PubMed ID: 8052760
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hypertension in renal allograft patients: does drug selection make a difference?
    Curtis JJ
    Kidney Int Suppl; 1997 Dec; 63():S75-7. PubMed ID: 9407427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of renoparenchymal hypertension in chronic glomerulonephritis with normal and impaired renal function].
    Stefanov G; Tishkov I; Todorova L
    Vutr Boles; 1982; 21(5):49-53. PubMed ID: 7164406
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic and glomerular hypertension in progressive renal disease.
    Anderson S
    Kidney Int Suppl; 1988 Sep; 25():S119-21. PubMed ID: 3054227
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension and renal artery stenosis: seral observations on 54 patients treated medically.
    Sheps SG; Osmundson PJ; Hunt JC; Schirger A; Fairbairn JF
    Clin Pharmacol Ther; 1965; 6(6):700-9. PubMed ID: 5846407
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment problems of nephrogenic arterial hypertension].
    Abrarova ER; Kosorukova NN
    Ter Arkh; 1996; 68(6):77-82. PubMed ID: 8771695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factors in renal vascular lesions in experimental hypertension].
    Yamaguchi H
    Jpn Circ J; 1966 Dec; 30(12):1623-33. PubMed ID: 6013027
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nephrogenic hypertension--drug therapy].
    Rahn KH
    Verh Dtsch Ges Inn Med; 1989; 95():41-5. PubMed ID: 2690512
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension.
    Mimran A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S45-50. PubMed ID: 1382165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.